PET-CT Diagnostic and Evaluation Role in Patients with Nodal Lymphoma

Abstract

Background : The most prevalent hematological malignancy is malignant lymphoma, which makes up ~8% of all adult malignancies. Non-Hodgkin lymphoma and Hodgkin disorder are two types of lymphoid neoplasms. Aim : To examine how positron emission tomography/computed tomography (PET/CT) may be used to diagnose nodal lymphoma, analyze the effectiveness of 18-FDG-PET/CT in the fi rst staging of nodal lymphoma, analyze the function of PET-CT in patient monitoring both during and after the therapeutic course, and examine the function of PET-CT in foretelling and spotting relapses. Patients and methods : A total of 30 patients (12 females and 18 males; 11 Hodgkin disorder and 19 non-Hodgkin disorder) with histologically con fi rmed malignant lymphoma were enrolled in this investigation. They were split into three groups judging by the outcomes of the PET/CT examination. Results : CT for diagnosis was compared with PET/CT results. The current study demonstrated the critical relevance of PET/CT in lymphoma staging, monitoring therapeutic response, and follow-up. The present investigation demonstrated the signi fi cance of 18F-FDG. When it comes to the early staging of lymphomas, PET/CT has shown to be a valuable tool in the treatment of lymphomas. PET/CT exhibited substantial effects on early and delayed therapy response evaluation. Conclusion : The outcomes of the present research highlighted the value of 18F-FDG PET/CT as a technique for the fi rst staging of lymphomas. Comparing PET/CT with diagnostic CT has major consequences for early and delayed evaluation of therapy response.